Paxman AB (PAX) - Total Liabilities
Based on the latest financial reports, Paxman AB (PAX) has total liabilities worth Skr59.89 Million SEK (≈ $6.45 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Paxman AB - Total Liabilities Trend (2016–2024)
This chart illustrates how Paxman AB's total liabilities have evolved over time, based on quarterly financial data. See working capital position of Paxman AB to evaluate short-term liquidity relative to the company's equity base.
Paxman AB Competitors by Total Liabilities
The table below lists competitors of Paxman AB ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
C-Rad AB (publ)
ST:CRAD-B
|
Sweden | Skr153.60 Million |
|
Donegal Group B Inc
NASDAQ:DGICB
|
USA | $1.20 Billion |
|
Hunter Group ASA
OL:HUNT
|
Norway | Nkr349.00K |
|
Lake Shore Bancorp Inc
NASDAQ:LSBK
|
USA | $579.63 Million |
|
Waterco Ltd
AU:WAT
|
Australia | AU$134.40 Million |
|
Raj Rayon Industries Limited
NSE:RAJRILTD
|
India | Rs4.52 Billion |
|
Alpha Cognition Inc
NASDAQ:ACOG
|
USA | $12.39 Million |
|
Orbitech Co. Ltd
KQ:046120
|
Korea | ₩56.53 Billion |
Liability Composition Analysis (2016–2024)
This chart breaks down Paxman AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Paxman AB market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.68 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.14 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.12 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Paxman AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Paxman AB (2016–2024)
The table below shows the annual total liabilities of Paxman AB from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | Skr63.24 Million ≈ $6.81 Million |
+42.08% |
| 2023-12-31 | Skr44.51 Million ≈ $4.79 Million |
-25.52% |
| 2022-12-31 | Skr59.76 Million ≈ $6.43 Million |
+47.25% |
| 2021-12-31 | Skr40.59 Million ≈ $4.37 Million |
-38.62% |
| 2020-12-31 | Skr66.12 Million ≈ $7.12 Million |
+16.80% |
| 2019-12-31 | Skr56.61 Million ≈ $6.09 Million |
+86.56% |
| 2018-12-31 | Skr30.34 Million ≈ $3.27 Million |
+136.33% |
| 2017-12-31 | Skr12.84 Million ≈ $1.38 Million |
+2.41% |
| 2016-12-31 | Skr12.54 Million ≈ $1.35 Million |
-- |
About Paxman AB
Paxman AB (publ), together with its subsidiaries, develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment worldwide. It serves various cancer centers and hospitals. The company has collaborated with the University of Huddersfield and the University of Leeds to develop a wearable medical cooling device; and the National University Hospital of … Read more